We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 191 results
  1. Synergistic antidepressant-like effect of citicoline and CB 1 agonist in male mice

    Background

    The endocannabinoid system plays a key role in the control of many emotional-correlated reactions such as stress, depressed mood, and...

    Aysan Amanzade, Fatemeh Khakpai, Mohammad-Reza Zarrindast in Psychopharmacology
    Article 21 February 2024
  2. The Combination of Citicoline and Nicotinamide Mononucleotide Induces Neurite Outgrowth and Mitigates Vascular Cognitive Impairment via SIRT1/CREB Pathway

    Vascular dementia (VD) is characterized with vascular cognitive impairment (VCI), which currently has few effective therapies in clinic. Neuronal...

    Ning Zhao, **aofeng Zhu, ... Tao Pang in Cellular and Molecular Neurobiology
    Article 09 October 2023
  3. Citicoline and COVID-19: vis-à-vis conjectured

    Coronavirus disease 2019 (COVID-19) is a current pandemic disease caused by a novel severe acute respiratory syndrome coronavirus virus respiratory...

    Hayder M. Al-kuraishy, Ali K. Al-Buhadily, ... Gaber El-Saber Batiha in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 05 September 2022
  4. The Role of P2Y6 Receptors in the Mechanisms of the Neuroprotective Effect of Citicoline

    Spontaneous bioelectrical activity of the brain and the duration of gas** were recorded in mice during modeling of global strangulation ischemia of...

    G. Z. Sufianova, A. G. Shapkin, ... A. A. Sufianov in Bulletin of Experimental Biology and Medicine
    Article 01 May 2023
  5. Nonlinear surface EMG analysis to detect the neuroprotective effect of citicoline in rat sciatic nerve crush injury

    Surface electromyography (sEMG) is a method involving physiological signals with a complex behavior. The aim is to analyze the sEMG signals by...

    Serife G. Çalışkan, Mehmet D. Bilgin in Medical & Biological Engineering & Computing
    Article 06 August 2022
  6. Effects of Citicoline on Structural/Functional Consequences of Focal Ischemia of the Rat Brain

    Effects of citicoline on the volume of ischemically damaged cerebral tissue, dynamics of neurological deficiency, and indices of neurobehavioral...

    O. P. Mankivska, N. V. Chaika, G. G. Skibo in Neurophysiology
    Article 25 February 2022
  7. Citicoline Modulates Glaucomatous Neurodegeneration Through Intraocular Pressure-Independent Control

    Glaucoma is a neurodegenerative disease that causes progressive, irreversible vision loss. Currently, intraocular pressure (IOP) is the only...

    Yolandi van der Merwe, Matthew C. Murphy, ... Kevin C. Chan in Neurotherapeutics
    Article 13 April 2021
  8. Serum Levels of the Biomarkers Associated with Astrocytosis, Neurodegeneration, and Demyelination: Neurological Benefits of Citicoline Treatment of Patients with Ischemic Stroke and Atrial Fibrillation

    Ischemic stroke is a main complication of atrial fibrillation (cardiac arrhythmia). The aim of our study was to estimate the effects of citicoline...

    O. V. Kuryata, Yu. S. Kushnir, ... A. A. Tykhomyrov in Neurophysiology
    Article 01 January 2021
  9. Clinical Trials in Fragile X-Associated Tremor/Ataxia Syndrome

    Fragile X-associated tremor/ataxia syndrome (FXTAS) is a rare, adult-onset neurodegenerative movement disorder occurring in some carriers of a 55–200...
    Erin E. Robertson, Joan A. O’Keefe, Deborah A. Hall in Trials for Cerebellar Ataxias
    Chapter 2023
  10. Drug Synergism as the Basis of Rational Neuroprotection

    Optimization of the choice of neuroprotective therapy regimens in patients with cerebrovascular diseases (CVD), taking into account the synergism of...

    M. V. Putilina, N. V. Teplova in Neuroscience and Behavioral Physiology
    Article 01 October 2022
  11. Selection of Neuroprotective Therapy in Patients with Chronic Cerebral Ischemia Taking Account of the Synergism of Drug Interactions

    Objective. To optimize selection of neuroprotective treatment protocols in patients with chronic cerebral ischemia taking account of synergism in...

    O. A. Gromova, I. Yu. Torshin, ... K. V. Rudakov in Neuroscience and Behavioral Physiology
    Article 05 May 2021
  12. Studies of the Membrane-Protecting Potential of the Combination of 2-Ethyl-6-Methyl-Hydroxypyridine Succinate and Citicoline

    Objectives. To assess changes in the phospholipid composition of blood plasma in patients with chronic cerebrovascular disease using the...

    E. Yu. Solovyeva, A. N. Karneev, ... G. M. Sorokoumova in Neuroscience and Behavioral Physiology
    Article 15 July 2019
  13. Therapeutic management of ischemic stroke

    Stroke is the third leading cause of years lost due to disability and the second-largest cause of mortality worldwide. Most occurrences of stroke are...

    Priya Bindal, Vishal Kumar, ... Arti Singh in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 15 November 2023
  14. Analysis of Fecal Microbiota in Patients with Hypertension Complicated with Ischemic Stroke

    Ischemic stroke is a disease with a very high incidence in the clinic, and hypertension is the most important variable risk factor of ischemic...

    Yitong Jiang, Chunhua Liu, ... **aowei Zhang in Journal of Molecular Neuroscience
    Article 26 September 2023
  15. Molecular and Clinical Aspects of the Action of Cytidine Diphosphocholine on Cognitive Functions

    Objectives. To systematize publications on drugs based on cytidine diphosphocholine (CDP-choline). Materials and methods. Systematic computer...

    O. A. Gromova, I. Yu. Torshin, ... T. E. Bogacheva in Neuroscience and Behavioral Physiology
    Article 01 March 2022
  16. An Understated Comorbidity: The Impact of Homelessness on Traumatic Brain Injury

    Traumatic brain injury (TBI), a neurovascular injury caused by external force, is a common diagnosis among veterans and those experiencing...

    M. Monsour, J.-Y. Lee, C.V. Borlongan in Neurotherapeutics
    Article 28 August 2023
  17. Genotoxicity of Psychotropic Drugs in Experimental and Clinical Studies

    Data from studies of the genotoxic activity of psychotropic drugs published over the past 25 years were analyzed. Information describing the...

    A. D. Durnev, N. V. Eremina, ... L. G. Kolik in Neuroscience and Behavioral Physiology
    Article 01 June 2023
  18. Adjunctive cytoprotective therapies in acute ischemic stroke: a systematic review

    With the introduction of endovascular thrombectomy (EVT), a new era for treatment of acute ischemic stroke (AIS) has arrived. However, despite the...

    I. A. Mulder, E. T. van Bavel, ... J. M. Coutinho in Fluids and Barriers of the CNS
    Article Open access 19 October 2021
  19. Pharmacological Approaches in the Augmentation and Recovery of Brain Function

    Pharmacological intervention for the augmentation of brain function in healthy individuals and for recovery after neurological conditions has reached...
    Dafin F. Mureșanu, Codruța Bîrle, ... Ștefan Strilciuc in Modern Approaches to Augmentation of Brain Function
    Chapter 2021
  20. Impairments to Cognitive Control in Patients with Somatoform Disorders and Their Treatment

    Objectives. To study impairments to cognitive control in patients with somatoform dysfunction of the autonomic nervous system (somatoform disorder –...

    L. S. Chutko, S. Yu. Surushkina, ... M. B. Volov in Neuroscience and Behavioral Physiology
    Article 28 December 2019
Did you find what you were looking for? Share feedback.